What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?

被引：9
|
作者：
Adams, J. D. [1 ]
Vella, Adrian [1 ]
机构：
[1] Mayo Clin, Coll Med, Endocrine Res Unit, Dept Endocrinol Diabet & Nutr, 200 First St SW,Rm 5-194 Joseph, Rochester, MN 55905 USA
来源：
METABOLIC SYNDROME AND RELATED DISORDERS | 2018年 / 16卷 / 08期
基金：
美国国家卫生研究院;
关键词：
common genetic variation; insulin secretion; insulin action; type; 2; diabetes; PATHWAY EFFECTOR TCF7L2; INSULIN-SECRETION; BETA-CATENIN; SUSCEPTIBILITY GENE; GLUCOSE-METABOLISM; PROGLUCAGON GENE; CELL FUNCTION; WNT; POLYMORPHISMS; EXPRESSION;
D O I：
10.1089/met.2018.0024
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion and/or insulin resistance. Among the various genetic factors associated with T2DM, a common genetic variant within the transcription factor 7-like 2 locus (TCF7L2) confers the greatest genetic risk for development of the disease. However, the mechanism(s) by which TCF7L2 predisposes to diabetes remain uncertain. Here we review the current literature pertaining to the potential mechanisms by which TCF7L2 confers risk of T2DM, using genetic variation as a probe to understand the pathogenesis of the disease.
引用
收藏
页码：383 / 389
页数：7
相关论文
共 50 条
  • [1] Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans
    Laurenti, Marcello C.
    Dalla Man, Chiara
    Varghese, Ron T.
    Andrews, James C.
    Rizza, Robert A.
    Matveyenko, Aleksey
    De Nicolao, Giuseppe
    Cobelli, Claudio
    Vella, Adrian
    JCI INSIGHT, 2020, 5 (07)
  • [2] Diabetes-Associated Variation in TCF7L2 Is Not Associated With Hepatic or Extrahepatic Insulin Resistance
    Varghese, Ron T.
    Viegas, Ivan
    Barosa, Cristina
    Marques, Catia
    Shah, Meera
    Rizza, Robert A.
    Jones, John G.
    Venal, Adrian
    DIABETES, 2016, 65 (04) : 887 - 892
  • [3] An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus?
    van de Bunt, Martijn
    DIABETOLOGIA, 2016, 59 (11) : 2292 - 2294
  • [4] An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus?
    Martijn van de Bunt
    Diabetologia, 2016, 59 : 2292 - 2294
  • [5] Type 2 diabetes-associated genetic variants of FTO, LEPR, PPARg, and TCF7L2 in gestational diabetes in a Brazilian population
    Anghebem-Oliveira, Mauren Isfer
    Martins, Bruna Rodrigues
    Alberton, Dayane
    de Souza Ramos, Edneia Amancio
    Picheth, Geraldo
    de Moraes Rego, Fabiane Gomes
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (03): : 238 - 248
  • [6] TCF7L2 genetic defect and type 2 diabetes
    Stéphane Cauchi
    Philippe Froguel
    Current Diabetes Reports, 2008, 8 : 149 - 155
  • [7] The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
    Grant, Struan F. A.
    DIABETES CARE, 2019, 42 (09) : 1624 - 1629
  • [8] TCF7L2 Genetic Defect and Type 2 Diabetes
    Cauchi, Stephane
    Froguel, Philippe
    CURRENT DIABETES REPORTS, 2008, 8 (02) : 149 - 155
  • [9] The Longitudinal Effect of Diabetes-Associated Variation in TCF7L2 on Islet Function in Humans
    Zeini, Maya
    Laurenti, Marcello C.
    Egan, Aoife M.
    Muthusamy, Kalpana
    Ramar, Anisha
    Vella, Emma
    Bailey, Kent R.
    Cobelli, Claudio
    Dalla Man, Chiara
    Vella, Adrian
    DIABETES, 2024, 73 (09)
  • [10] No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
    Mathiesen, David S.
    Bagger, Jonatan, I
    Hansen, Katrine B.
    Junker, Anders E.
    Plamboeck, Astrid
    Harring, Signe
    Idorn, Thomas
    Hornum, Mads
    Holst, Jens J.
    Jonsson, Anna E.
    Hansen, Torben
    Vilsboll, Tina
    Lund, Asger
    Knop, Filip K.
    ENDOCRINE CONNECTIONS, 2020, 9 (12): : 1221 - 1232
12345